CN101926958B - Chinese and Western medicine composition containing carbenoxolone sodium - Google Patents
Chinese and Western medicine composition containing carbenoxolone sodium Download PDFInfo
- Publication number
- CN101926958B CN101926958B CN2009102444190A CN200910244419A CN101926958B CN 101926958 B CN101926958 B CN 101926958B CN 2009102444190 A CN2009102444190 A CN 2009102444190A CN 200910244419 A CN200910244419 A CN 200910244419A CN 101926958 B CN101926958 B CN 101926958B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- chinese medicine
- chinese
- western medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a synergistic medicinal composition containing carbenoxolone sodium and Chinese medicine extract, and application thereof in preparing medicines for treating gastric ulcer.
Description
The present invention relates to a kind of medicine for the treatment of gastropathy, is the compositions of being made by Chinese crude drug extract and Western medicine, is particularly suitable for the medicine as treatment gastritis, peptic ulcer gastropathy such as (containing gastric ulcer and duodenal bulbar ulcer).
Gastropathy, particularly gastritis (shallow harmony in the exterior atrophic), peptic ulcer (containing gastric ulcer and duodenal bulbar ulcer) is a kind of commonly encountered diseases, frequently-occurring disease.At present, the medicine for the treatment of these diseases is more, the curative effect of the degree of having nothing in common with each other, but generally speaking, curative effect is not ideal enough, and relapse rate is higher after the drug withdrawal, and with regard to better medicine at present commonly used: its effective percentage is below 80%, and its relapse rate is more than 36%.
Purpose of the present invention just is: invent a kind of composition medicine of being made up of Chinese medicine extract and Western medicine for the treatment of gastropathy, to improve the treatment curative effect and to reduce relapse rate.
The present invention realizes its purpose like this: the present composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, % counts with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20.
The summation of its each component is 100%.
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and medical material is concocted with conventional concocting method, be ground into powder, decoct with water, filtration, concentrated filtrate is to thick paste, drying.
Pharmaceutical composition Chinese medicine and western medicine of the present invention in addition is a carbenoxolone sodium, and the weight ratio of Chinese medicine extract and Western medicine is 64: 1.
Chinese medicine extract prescription in the pharmaceutical composition of the present invention is from the embodiment 1 of CN1055015C.
Pharmaceutical composition of the present invention can be made into various peroral dosage forms, and three times on the one, each 2 grams, seriously ill person's four times a day, boiled water is taken after mixing it with water.For gastritis (shallow table or atrophic), 7 is a course of treatment, serve on 2-3 the course of treatment, and for peptic ulcer (containing gastric ulcer and bulboduodenal ulcer), be a course of treatment January, serve on 2-3 the course of treatment.Taboo: dry peppery, the raw food food such as hard of fasting.
Clinical effectiveness:
To peptic ulcer (containing gastric ulcer and duodenal bulbar ulcer) 37 examples, treat 5 courses of treatment after.Through hospital's fiber microscopy and biopsy, 17 examples of wherein fully recovering, effective 17 examples, invalid 3 examples.Average total effective rate is 91.9%, and the toxic side effect reaction is found at the end.And with the pure Chinese medicine extract or the carbenoxolone sodium of Isodose, effective percentage is respectively 64% and 83%.
The treatment standard declaration: recovery from illness refers to after 2-3 the course of treatment 1 clinical symptom disappearance.Through fiber microscopy and biopsy, foci disappearance.Effectively refer to after 2～8 courses of treatment, through fiber microscopy and biopsy, clinical symptom disappearance, the lesion tissue scope is dwindled.Invalid finger is after 2-3 the course of treatment, and clinical symptoms does not have significant change before fiber microscopy and biopsy and treatment.
Pharmacology and resultant effect analysis.The Rhizoma Curcumae heat-clearing and toxic substances removing of this medicine with the same usefulness of Rhizoma Coptidis, strengthens heat-clearing toxin-expelling functions, Corium elephatis granulation promoting good medicine, and dried Alumen is held back skin ulcer, reuses poliosis, the same usefulness of three flavors, granulation promoting power is grand, and it is remarkable to hold back skin ulcer, promotes the lesion tissue reparation effectively, and well can end digestive tract hemorrhage preferably; Semen Trichosanthis a surname spleen helps circulation of qi promoting intestinal stasis relieving class efficacy of drugs such as Radix Et Rhizoma Nardostachyos more remarkable, has effectively promoted the recovery of gastric motility function, reuses Rhizoma Corydalis, Radix Aristolochiae, fast and effeciently pain relieving.Therefore, comprehensive compatibility, this Chinese patent medicine is heat-clearing and toxic substances removing effectively, and carbenoxolone sodium can effectively be protected gastric mucosa.The Chinese medicine and western medicine binding energy fundamentally reaches therapeutic purposes.
Claims (2)
1. compositions for the treatment of gastric ulcer, said composition comprises Chinese medicine extract and Western medicine, and wherein Chinese medicine extract is prepared by following method:
Chinese medicine medical material component and proportional quantity thereof, % counts with percentage ratio:
Rhizoma Alpiniae Officinarum 4, the Radix Aucklandiae 3, Os Sepiae 3, Rhizoma Curcumae 10, Amomum globosum loureiro 1,
Radix Et Rhizoma Nardostachyos 6, dried Alumen 3, Endothelium Corneum Gigeriae Galli 3, Rhizoma Coptidis 3, the Pseudobulbus Bletillae (Rhizoma Bletillae) 10,
Rhizoma Corydalis 11, Fructus Hordei Germinatus 1, Radix Aristolochiae 20, Semen Trichosanthis 2, Corium elephatis 20,
The summation of its each component is 100%,
Earlier Chinese crude drug is cleaned, press the proportional quantity metering, and medical material is concocted with conventional concocting method, be ground into powder, decoct with water, filtration, concentrated filtrate is to thick paste, drying;
Western medicine is a carbenoxolone sodium, and the weight ratio of Chinese medicine extract and Western medicine is 64: 1.
2. the purposes of compositions as claimed in claim 1 in the medicine of preparation treatment gastric ulcer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102444190A CN101926958B (en) | 2009-12-30 | 2009-12-30 | Chinese and Western medicine composition containing carbenoxolone sodium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102444190A CN101926958B (en) | 2009-12-30 | 2009-12-30 | Chinese and Western medicine composition containing carbenoxolone sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101926958A CN101926958A (en) | 2010-12-29 |
| CN101926958B true CN101926958B (en) | 2011-12-21 |
Family
ID=43366562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102444190A Expired - Fee Related CN101926958B (en) | 2009-12-30 | 2009-12-30 | Chinese and Western medicine composition containing carbenoxolone sodium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101926958B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281209B (en) * | 2017-07-19 | 2019-05-24 | 本溪国家中成药工程技术研究中心有限公司 | A kind of pharmaceutical composition of anti-gastric-ulcer and preparation method thereof and purposes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178111A (en) * | 1997-10-21 | 1998-04-08 | 肖启美 | Weijisan for gastropathy |
| CN1650878A (en) * | 2004-11-27 | 2005-08-10 | 宁夏大学 | Inclusion compound of glycyrrhizic acid or its derivative and alkaloid, and its preparation method |
| CN101066416A (en) * | 2007-06-05 | 2007-11-07 | 徐雪娟 | Medicine containing rabeprazole for treating gastric ulcer |
-
2009
- 2009-12-30 CN CN2009102444190A patent/CN101926958B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1178111A (en) * | 1997-10-21 | 1998-04-08 | 肖启美 | Weijisan for gastropathy |
| CN1650878A (en) * | 2004-11-27 | 2005-08-10 | 宁夏大学 | Inclusion compound of glycyrrhizic acid or its derivative and alkaloid, and its preparation method |
| CN101066416A (en) * | 2007-06-05 | 2007-11-07 | 徐雪娟 | Medicine containing rabeprazole for treating gastric ulcer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101926958A (en) | 2010-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066434B (en) | Omeprazole-containing medicine | |
| CN100584371C (en) | Chinese-western medicine composition containing carafate for treating gastric ulcer | |
| CN100515484C (en) | Iprazole containing medicine | |
| CN100534516C (en) | Medicine containing rabeprazole for treating gastric ulcer | |
| CN100515485C (en) | Medicine composition for treating gastric ulcer | |
| CN1055015C (en) | Weijisan for gastropathy | |
| CN101926958B (en) | Chinese and Western medicine composition containing carbenoxolone sodium | |
| CN100574793C (en) | The medicine that contains ranitidine | |
| CN101066418B (en) | Medicine containing colloidal bismuth for treating gastric uncer | |
| CN101732663B (en) | Rebamipide-containing Chinese and western medicinal composition | |
| CN101732664B (en) | Enprostil-containing Chinese and Western medicinal composition for treating gastric ulcer | |
| CN101773645B (en) | Chinese-western medicine composition containing spizofurone | |
| CN101773646B (en) | Chinese and Western medicine composition containing proglumide | |
| CN101797356B (en) | Traditional Chinese medicine and Western medicine composition containing Lafutidine | |
| CN101721657B (en) | Chinese and western medicine composition containing licorzinc | |
| CN101797358B (en) | Medicinal composition containing roxatidine | |
| CN101797359B (en) | Chinese and western medicinal composition containing pantoprazole | |
| CN101797357B (en) | Chinese-western medicinal composition containing lansoprazole | |
| CN101810828B (en) | Combination medicament containing teprenone | |
| CN101797364B (en) | Marzulene-s-containing combined medicine | |
| CN1255165C (en) | Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method | |
| CN1167453C (en) | A powder for the treatment of hemorrhoid | |
| CN1270754C (en) | Gastropathy treating medicine and its preparation | |
| CN103356942B (en) | Medicine for treating chronic gastritis, gastric ulcer and/or duodenal ulcer and preparation method thereof | |
| CN102847000A (en) | A Chinese medicinal formulation for treating lung abscess |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xixin Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention |
|
| ASS | Succession or assignment of patent right |
Owner name: NINGBO YINZHOU FURUIDA BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG XIXIN Effective date: 20111018 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Gang Inventor after: Zhang Xixin Inventor before: Zhang Xixin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG XIXIN TO: LI GANG ZHANG XIXIN Free format text: CORRECT: ADDRESS; FROM: 100020 CHAOYANG, BEIJING TO: 315100 NINGBO, ZHEJIANG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20111018 Address after: 315100 Zhejiang city of Ningbo province Yinzhou District Zhonggongmiao Street Tiantong Road No. 1388 room 3624 Applicant after: Ningbo Yinzhou Furuida Biotechnology Co., Ltd. Address before: 100020, B320, building 3, Dacheng International, No. 80 East Fourth Ring Road, Beijing, Chaoyang District Applicant before: Zhang Xixin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Xixin Document name: Notification of Passing Examination on Formalities |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111221 Termination date: 20121230 |